Stem Cell Therapy (SCT) is not useful for the treatment of which one of the following ailments?

1. Basics of Stem Cells: Totipotency to Unipotency (basic)

In the human body, most cells are highly specialized. For instance, a nerve cell is long and branched to carry signals, while a muscle cell is spindle-shaped for contraction Science, Class VIII, The Invisible Living World: Beyond Our Naked Eye, p.13. However, these specialized cells cannot change their jobs; a skin cell cannot suddenly become a neuron. This is where stem cells come in. They are the body’s raw materials — 'unspecialized' cells capable of proliferating (dividing) and differentiating into various specialized cell types under the right circumstances Science, Class X, How do Organisms Reproduce?, p.116.

The journey from a single fertilized egg to a complex human being is a story of potency — the ability of a cell to differentiate into other cell types. As a cell matures, its 'potential' usually narrows. We can classify stem cells into four main categories based on this potential:

Type of Potency	Capability	Example
Totipotent	The 'Total' package. Can form any cell type in the body PLUS the placenta/umbilical cord.	Zygote (Fertilized egg)
Pluripotent	Can form almost any cell type in the adult body (all three germ layers), but cannot form a whole organism because they can't make the placenta.	Embryonic Stem Cells (ESCs)
Multipotent	Can develop into more than one cell type, but are limited to a specific 'family' or tissue.	Hematopoietic (Blood) stem cells
Unipotent	Can only produce one cell type, but unlike regular cells, they can self-renew (make copies of themselves).	Skin stem cells

Sources: Science, Class VIII (Revised ed 2025), The Invisible Living World: Beyond Our Naked Eye, p.13; Science, Class X (NCERT 2025 ed.), How do Organisms Reproduce?, p.116

2. Induced Pluripotent Stem Cells (iPSCs) (intermediate)

In our previous discussion, we explored how cells have unique shapes and structures—like the long, branched nerve cells or spindle-shaped muscle cells—to perform specific functions Science, Class VIII, The Invisible Living World: Beyond Our Naked Eye, p.13. For a long time, scientists believed that once a cell "grew up" and became specialized (differentiated), it could never go back. Induced Pluripotent Stem Cells (iPSCs) turned this belief on its head.

iPSCs are essentially adult, specialized cells (such as skin or blood cells) that have been reprogrammed in a laboratory to behave like embryonic stem cells. By introducing specific genes, scientists "reset" the cell's clock, stripping away its specialized identity and returning it to a state of pluripotency. This means the cell regains the remarkable capability of growing, proliferating, and making almost any other cell type in the body Science, Class X, How do Organisms Reproduce?, p.116.

The discovery of iPSCs (led by Shinya Yamanaka in 2006) is a landmark in regenerative medicine for two main reasons:

• Ethical Advantage: Unlike embryonic stem cells, iPSCs do not require the destruction of an embryo, bypassing a major moral and legal hurdle.
• Immune Compatibility: Because iPSCs can be made from a patient’s own cells, the body is far less likely to reject them when they are used in therapy. It is truly "personalized" medicine.

Feature	Adult Stem Cells	iPSCs
Source	Found in specific tissues (e.g., bone marrow).	Created from any adult cell (e.g., skin).
Potency	Multipotent (can only form a limited range of cells).	Pluripotent (can form almost any cell in the body).
Origin	Naturally occurring.	Artificially induced in a lab.

Sources: Science, Class VIII, The Invisible Living World: Beyond Our Naked Eye, p.13; Science, Class X, How do Organisms Reproduce?, p.116

3. Mechanisms of Regenerative Medicine (basic)

Regenerative medicine is the science of "biological restoration." Unlike traditional medicine, which often focuses on managing symptoms, regenerative medicine seeks to repair, replace, or restore damaged cells, tissues, and organs. This mechanism relies on the body’s innate ability to heal itself, amplified through modern science. At the heart of this process are specialized cells that possess two unique abilities: the power to proliferate (multiply into large numbers) and the power to differentiate (transform into specific cell types like nerves, muscles, or blood).

To understand the mechanism, think of every cell as containing a detailed instruction manual known as genes. These instructions guide the cell on how to build specific structures, such as bone or skin Science, Class VIII, Our Home: Earth, a Unique Life Sustaining Planet, p.220. In regenerative therapy, scientists provide the right environment or chemical signals—often in the form of hormones—to trigger these instructions. For example, in a lab setting (tissue culture), a small group of cells can be encouraged to form a callus (an unorganized mass of cells) and then be directed to grow into mature, functional tissues Science, Class X, How do Organisms Reproduce?, p.118.

In the human body, this mechanism is applied in several groundbreaking ways:

• Cell Replacement: Replacing diseased blood cells in leukemia patients with healthy, blood-forming stem cells.
• Tissue Repair: Mobilizing cells to repair damaged brain tissue after an injury or restoring the retina to improve vision.
• Self-Healing: Utilizing the natural "regeneration" ability seen in simpler organisms, where specialized cells proliferate to grow back lost body parts, and applying those principles to human healing Science, Class X, How do Organisms Reproduce?, p.116.

Sources: Science, Class VIII, Our Home: Earth, a Unique Life Sustaining Planet, p.220; Science, Class X, How do Organisms Reproduce?, p.116; Science, Class X, How do Organisms Reproduce?, p.118

4. Ethical and Regulatory Framework in India (exam-level)

To understand the regulation of Stem Cell Therapy (SCT) in India, we must first look at the National Guidelines for Stem Cell Research, which act as the ethical compass for this field. In India, SCT is not regulated as a simple surgical procedure but rather as a 'Drug' under the Drugs and Cosmetics Act, 1940. This means any stem cell product must undergo rigorous clinical trials before it can be marketed. The governance is a collaborative effort between the Department of Biotechnology (DBT) and the Indian Council of Medical Research (ICMR). These bodies ensure that while we pursue 'novel therapeutics' to treat diseases, we do not compromise on patient safety or ethical standards Nitin Singhania, Indian Economy, p.618.

The regulatory framework divides stem cell research into three distinct categories based on their ethical sensitivity and potential for misuse:

Category	Description	Examples
Permissible	Research with low ethical risk using well-established cell lines or adult stem cells.	In-vitro studies, adult stem cell research with consent.
Restricted	Research requiring close monitoring and special permits from the National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT).	Human Embryonic Stem Cell (hESC) research, use of 'spare' embryos.
Prohibited	Practices that are strictly banned due to extreme ethical concerns.	Human reproductive cloning, germline gene therapy, and growing human embryos beyond 14 days.

Institutional oversight is the first line of defense. Every lab or hospital working with stem cells must register with the National Online Portal for Stem Cell Research and have an internal Institutional Committee for Stem Cell Research (IC-SCR). For actual clinical application and licensing, the Central Drugs Standard Control Organisation (CDSCO), led by the Drug Controller General of India (DCGI), provides the final stamp of approval. Specialized national institutes, such as the National Institute of Immunology (NII) in New Delhi and the Centre for DNA Fingerprinting and Diagnostics (CDFD) in Hyderabad, provide the technical and diagnostic backbone required for such advanced biotechnology Majid Hussain, Environment and Ecology, p.82.

Sources: Indian Economy, Nitin Singhania, Sustainable Development and Climate Change, p.618; Environment and Ecology, Majid Hussain, Major Crops and Cropping Patterns in India, p.82

5. SCT in Hematology and Oncology (intermediate)

In the realm of hematology (the study of blood) and oncology (the study of cancer), stem cell therapy is not just an experimental hope—it is a cornerstone of modern treatment. The primary goal is often Hematopoietic Stem Cell Transplantation (HSCT). This involves replacing a patient's damaged or diseased bone marrow with healthy Hematopoietic Stem Cells (HSCs). These master cells are the 'ancestors' of all blood components: red blood cells for oxygen transport, white blood cells for immunity, and platelets for clotting. Since bone marrow is a vital tissue that can be donated to save lives, it is categorized alongside major organ transplants like kidneys or lungs Science, Class X, Life Processes, p.98.

Why do we use stem cells for blood cancers like Leukemia or Lymphoma? In these diseases, the body produces abnormal, non-functional blood cells that crowd out the healthy ones. Furthermore, life-saving treatments like high-dose chemotherapy or intensive radiation—while effective at killing cancer—are highly toxic. They can destroy the patient’s healthy bone marrow, leading to severe bleeding and a loss of the ability to fight infection Environment and Ecology, Majid Hussain, Environmental Degradation and Management, p.44. In this context, a stem cell transplant acts as a 'rescue' mechanism, providing a fresh source of cells to rebuild the entire blood system after the cancer has been cleared out.

There are two main types of transplants based on the source of the cells:

• Autologous: The patient’s own stem cells are harvested before high-dose treatment and returned later.
• Allogeneic: Stem cells are obtained from a matching donor.

While pioneering research, such as that by Dr. Kamal Ranadive, has deepened our understanding of how viruses and environment trigger cancer Science, Class VIII, Health: The Ultimate Treasure, p.37, SCT remains a complex procedure. It requires the patient to be in a relatively stable physical condition. For instance, if a patient has significant comorbidities like kidney failure, the intensive drugs used during a transplant can be too dangerous, making such conditions a 'relative contraindication' where the risks might outweigh the benefits.

Sources: Science, Class X (NCERT 2025 ed.), Life Processes, p.98; Environment and Ecology, Majid Hussain (Access publishing 3rd ed.), Environmental Degradation and Management, p.44; Science, Class VIII, NCERT (Revised ed 2025), Health: The Ultimate Treasure, p.37

6. SCT in Neurology and Ophthalmology (exam-level)

In the realm of regenerative medicine, Stem Cell Therapy (SCT) is most transformative when applied to the Central Nervous System (CNS) and the Human Eye. Both systems are highly specialized, and because mature neurons and certain ocular tissues have a limited capacity to repair themselves naturally, stem cells offer a "biological backup" to restore function.

In Neurology, SCT targets the brain and spinal cord—the body's main coordinating centers Science, Class X (NCERT 2025 ed.), Chapter 6: Control and Coordination, p.103. While the brain manages complex mechanisms like thinking and voluntary actions (e.g., writing or walking), specific regions like the cerebellum are responsible for the precision of these actions and maintaining balance Science, Class X (NCERT 2025 ed.), Chapter 6: Control and Coordination, p.104. When these regions are damaged by trauma or neurodegenerative diseases like Parkinson’s, stem cells are used to replace lost neurons or provide protective factors to mobilize existing neural stem cells for repair. This holds the potential to restore motor control and cognitive functions that were previously considered permanently lost.

In Ophthalmology, the focus is often on reversing blindness. Millions of people suffer from corneal blindness, which can often be cured through transplantation Science, Class X (NCERT 2025 ed.), Chapter 10: The Human Eye and the Colourful World, p.164. However, SCT takes this a step further by using Limbal Stem Cells to regenerate the corneal surface without needing a full donor organ. Additionally, stem cell research is targeting the retina to treat conditions like Macular Degeneration. By differentiating stem cells into Retinal Pigment Epithelium (RPE) cells, doctors can replace the damaged light-sensing layers of the eye, effectively "re-lighting" the gift of vision for the patient.

Field	Primary Target Tissue	Goal of Therapy
Neurology	Neurons, Astrocytes, Cerebellum	Restoring neural connections, balance, and voluntary motor control.
Ophthalmology	Cornea, Retina (RPE cells)	Regenerating the eye surface and light-sensing layers to cure blindness.

Sources: Science, Class X (NCERT 2025 ed.), Chapter 6: Control and Coordination, p.103; Science, Class X (NCERT 2025 ed.), Chapter 6: Control and Coordination, p.104; Science, Class X (NCERT 2025 ed.), Chapter 10: The Human Eye and the Colourful World, p.164

7. Limitations and Clinical Contraindications (exam-level)

While stem cell therapy (SCT) offers revolutionary potential, it is not a universal cure. As a student of medicine and policy, you must distinguish between **clinical indications** (where SCT is the standard treatment) and **limitations or contraindications** (where the therapy is either ineffective or too risky for the patient). Currently, the most successful and established applications of SCT are in treating blood cancers like leukemia and regenerating the cornea to restore vision. For example, a single pair of donated eyes can provide corneal tissue for up to four patients (Science, The Human Eye and the Colourful World, p.165). However, when the eye's internal structures, like the lens, are severely damaged by environmental factors like UV radiation, the success of simple regenerative procedures may be limited (Environment, Ozone Depletion, p.271).

A significant clinical limitation arises from the patient's overall health, particularly regarding **comorbidities**. In many high-intensity stem cell procedures, such as allogeneic transplants (where cells come from a donor), the patient's body must be strong enough to withstand the preparatory treatment. Conditions like **chronic kidney failure** are often viewed as a relative contraindication. While dialysis can manage nitrogenous waste accumulation (Science, Life Processes, p.97), the systemic strain of organ failure often makes the patient ineligible for standard stem cell transplants. Unlike blood cancers, using stem cells to actually *repair* a failing kidney is still in the experimental phase and is not yet a standard clinical practice.

Feature	Established Clinical Indication	Current Clinical Limitation
Examples	Leukemia, Lymphoma, Corneal scarring.	Advanced Kidney Failure, Chronic Heart Failure.
Status	Standard of Care; high success rates.	Experimental or High-Risk (Contraindicated).
Mechanism	Replacing hematopoietic or epithelial cells.	Attempting to regenerate complex solid organs.

Sources: Science, The Human Eye and the Colourful World, p.165; Environment, Ozone Depletion, p.271; Science, Life Processes, p.97

8. Solving the Original PYQ (exam-level)

Congratulations on mastering the fundamentals of cellular biology! Now, we apply those building blocks—specifically the pluripotency and regenerative potential of stem cells—to clinical reality. This question requires you to distinguish between established medical applications and areas where the technology is either experimental or currently limited. While you've learned that stem cells can theoretically become any cell type, the UPSC tests your knowledge of where this science is practically useful in current medicine versus where it faces significant hurdles.

To navigate this, let's walk through the options: we know from Science, class X (NCERT 2025 ed.) and clinical standards that Hematopoietic Stem Cell Transplantation is the gold standard for treating Cancer, particularly blood-related ones like leukemia. Similarly, modern regenerative medicine has made massive strides in Vision impairment through corneal and retinal repair, and in Brain injury by attempting to replace damaged neurons. However, the reasoning takes a turn with Kidney failure. While research is ongoing, it is currently categorized as a relative contraindication for many standard SCT procedures, meaning it is not a primary "useful" indication in the current medical landscape compared to the other three.

The common trap here is assuming that because stem cells can become any tissue, they are currently used for all organ failures. UPSC often uses "future potential" to distract you from "current utility." While lab research exists for all organs, Kidney failure (Option A) remains the one ailment on this list where SCT is not yet a standard or useful treatment. Always look for the option that represents a clinical limitation rather than a widely recognized success story like Cancer treatment.